Defining Study Populations in HIV Prevention Implementation Science Studies: A Case Comparison of 3 Ending the HIV Epidemic Projects.

IF 2.9 3区 医学 Q3 IMMUNOLOGY
Rebecca Giguere, Okeoma Mmeje, Viraj V Patel, Uriel R Felsen, Jenell S Coleman Fennell, Iván C Balán, Andrea Cheshure, Seul Ki Choi, Sara K Shaw Green, Willey Lin, Jonathan Morgan, José Bauermeister, Sylvie Naar
{"title":"Defining Study Populations in HIV Prevention Implementation Science Studies: A Case Comparison of 3 Ending the HIV Epidemic Projects.","authors":"Rebecca Giguere, Okeoma Mmeje, Viraj V Patel, Uriel R Felsen, Jenell S Coleman Fennell, Iván C Balán, Andrea Cheshure, Seul Ki Choi, Sara K Shaw Green, Willey Lin, Jonathan Morgan, José Bauermeister, Sylvie Naar","doi":"10.1097/QAI.0000000000003634","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Implementation studies include both recipient populations, who will benefit from the study's evidence-based intervention, and study populations, who will participate in the intervention and contribute data to implementation outcomes. Decision making around inclusion criteria for the study population and whether to include the recipient population have significant implications for study design. We present 3 case studies of HIV prevention implementation studies that feature diverse study populations and describe the decision-making process around defining study populations to share generalizable lessons for the field.</p><p><strong>Methods: </strong>We identified recipient and study populations for each study, described decision making regarding inclusion and exclusion criteria, and identified implications for measuring study aims.</p><p><strong>Results: </strong>HIV prevention interventions focus on pre-exposure prophylaxis uptake and HIV testing in settings such as emergency departments, obstetrics/gynecology clinical practices, and free HIV testing sites. These studies were designed to inform scale-up of intervention strategies based on effectiveness, affordability, and feasibility. Decisions about whom to include in the study populations were based on context, strategies, and implementation outcomes.</p><p><strong>Discussion: </strong>We identified important considerations across projects, including study context, strategies, and approaches. These factors can inform decisions around defining study populations to ensure successful measurement of study aims and sustainability of implementation outcomes.</p>","PeriodicalId":14588,"journal":{"name":"JAIDS Journal of Acquired Immune Deficiency Syndromes","volume":"98 5S","pages":"e124-e128"},"PeriodicalIF":2.9000,"publicationDate":"2025-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JAIDS Journal of Acquired Immune Deficiency Syndromes","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/QAI.0000000000003634","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Implementation studies include both recipient populations, who will benefit from the study's evidence-based intervention, and study populations, who will participate in the intervention and contribute data to implementation outcomes. Decision making around inclusion criteria for the study population and whether to include the recipient population have significant implications for study design. We present 3 case studies of HIV prevention implementation studies that feature diverse study populations and describe the decision-making process around defining study populations to share generalizable lessons for the field.

Methods: We identified recipient and study populations for each study, described decision making regarding inclusion and exclusion criteria, and identified implications for measuring study aims.

Results: HIV prevention interventions focus on pre-exposure prophylaxis uptake and HIV testing in settings such as emergency departments, obstetrics/gynecology clinical practices, and free HIV testing sites. These studies were designed to inform scale-up of intervention strategies based on effectiveness, affordability, and feasibility. Decisions about whom to include in the study populations were based on context, strategies, and implementation outcomes.

Discussion: We identified important considerations across projects, including study context, strategies, and approaches. These factors can inform decisions around defining study populations to ensure successful measurement of study aims and sustainability of implementation outcomes.

艾滋病预防实施科学研究中研究人群的界定——以3个终止艾滋病流行项目为例比较。
实施研究既包括将从研究的循证干预中受益的接受者人群,也包括将参与干预并为实施结果提供数据的研究人群。围绕研究人群的纳入标准以及是否纳入受体人群的决策对研究设计具有重要意义。我们提出了3个艾滋病毒预防实施研究的案例研究,这些研究具有不同的研究人群,并描述了围绕定义研究人群的决策过程,以分享该领域的可概括的经验教训。方法:我们确定了每项研究的接受者和研究人群,描述了关于纳入和排除标准的决策制定,并确定了测量研究目标的含义。结果:艾滋病毒预防干预措施侧重于在急诊、产科/妇科临床实践和免费艾滋病毒检测站点等环境中进行暴露前预防和艾滋病毒检测。这些研究旨在为基于有效性、可负担性和可行性的干预策略的扩大提供信息。决定将谁纳入研究人群是基于环境、策略和实施结果。讨论:我们确定了跨项目的重要考虑因素,包括研究背景、策略和方法。这些因素可以为确定研究人群的决策提供信息,以确保成功衡量研究目标和实施结果的可持续性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
5.80
自引率
5.60%
发文量
490
审稿时长
3-6 weeks
期刊介绍: JAIDS: Journal of Acquired Immune Deficiency Syndromes​ seeks to end the HIV epidemic by presenting important new science across all disciplines that advance our understanding of the biology, treatment and prevention of HIV infection worldwide. JAIDS: Journal of Acquired Immune Deficiency Syndromes is the trusted, interdisciplinary resource for HIV- and AIDS-related information with a strong focus on basic and translational science, clinical science, and epidemiology and prevention. Co-edited by the foremost leaders in clinical virology, molecular biology, and epidemiology, JAIDS publishes vital information on the advances in diagnosis and treatment of HIV infections, as well as the latest research in the development of therapeutics and vaccine approaches. This ground-breaking journal brings together rigorously peer-reviewed articles, reviews of current research, results of clinical trials, and epidemiologic reports from around the world.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信